Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3Hematologic Neoplasms 2Teratoma 1Stroke 1Pulmonary Disease, Chronic Obstructive 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Failure, Chronic 1Hepatitis B 1Hematopoietic and Lymphatic System Neoplasm 1Endometrial Clear Cell Adenocarcinoma 1Endodermal Sinus Tumor 1Diabetes Mellitus 1Coronary Artery Disease 1Colonic Neoplasms 1Carcinoma, Embryonal 1COVID-19 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Tenofovir 3entecavir 2tenofovir alafenamide 1human papillomavirus vaccine, L1 type 16, 18 1Standard of Care 1Practice Guidelines as Topic 1Lamivudine 1Engerix-B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hepatitis B × Practice Guidelines as Topic × Clear all
NCT03887702 2024-05-20

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

SWOG Cancer Research Network

Phase 3 Terminated
4 enrolled 5 charts

Hepatitis B

Data powered by HemOnc (CC BY 4.0) Colophon âš¡